ASSISTED LIVING CONCEPTS (NYSE: ALC)





$25.14 0.58 (2.36%)
Real-time 12:00:00 AM ET
Turn On
KEY STATS
52-Week High Price
27.86
52-Week Low Price
12.23
Avg Volume (3 Mo.)
0.00 M
Market Cap
0.25 B
P/E Ratio (TTM)
68.0
Diluted EPS (TTM)
1.27
Shares
11.63 M
Dividend Rate ($) / (%)
0.00/0.00
100%
0%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 13% - ALC has underperformed the S&P 500 by 13%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
BROOKDALE SENIOR LIVING (BKD) $18.20 -  $0.18(1.00%)2.17 B
KINDRED HEALTHCARE INC (KND) $16.74 -  $0.44(2.70%)0.64 B
SUN HEALTHCARE GROUP (SUNH) $8.31 -  $0.13(1.59%)0.35 B
ENSIGN GROUP INC THE (ENSG) $16.54 -  $0.09(0.54%)0.36 B
AMN HEALTHCARE (AHS) $8.52 -  $0.21(2.53%)0.28 B
SKILLED HEALTHCARE GRP... (SKH) $5.99 -  $0.06(0.99%)0.23 B
TRANSCEND SERVICES INC (TRCR) $19.13 -  $0.28(1.49%)0.16 B
SUNRISE SENIOR LIVING (SRZ) $3.30 -  $0.20(6.45%)0.16 B
FIVE STAR QLTY CARE INC (FVE) $3.18 -  $0.02(0.62%)0.11 B
ADVOCAT INC (AVCA) $6.89 -  $0.28(3.91%)0.04 B
STOCK ANALYSIS
There are currently no Stock Analysis.
ALC RELATED HEADLINES
arrow
Trading Review for Sunrise Senior Living Inc. Issued by StockPreacher.com
Trading Review for Sunrise Senior Living Inc. Issued by StockPreacher.com

by GlobeNewswire 10/20/2009
arrow
What's New in Healthcare
<ul> <li>Alexzas new drugs for schizophrenia and bi-polar diseases in Phase III</li> <li>Arigens oral drug for bleeding disorders</li> <li>4 Phase III trials for Cypress Bio</li> <li>Xomas drug for type II diabetes entering Phase II</li> </ul>

Wall Street Media 12/11/2008
arrow
FEATURE-Ripples from housing crisis slow US senior living
USA-HOUSING/ELDERLY (FEATURE):FEATURE-Ripples from housing crisis slow US senior living

Forbes.com 5/23/2008
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM2